7 Results for "

reflux esophagitis

" in MedChemExpress (MCE) Product Catalog:
Products (7)

7 Results for "reflux esophagitis" in MCE Product Catalog:

Cat. No.: HY-100412
CAS No.: 248919-64-4
Purity:  99.61%
Synonyms: AZD0865
Target:  

Proton Pump

Research Areas:  

Cancer

Linaprazan (AZD0865) can inhibit H+,K+ -ATPase in the stomach through K+ competitive binding, (IC50: 1.0 ± 0.2 μM), it has a strong inhibitory effect on acid. Linaprazan (AZD0865) can be used for research on reflux esophagitis with oral activity .
loading...
    loading...
Cat. No.: HY-100412A
CAS No.: 855998-67-3
Synonyms: AZD-0865 mesylate
Target:  

Proton Pump

Research Areas:  

Cancer

Linaprazan mesylate can inhibit H+,K+ -ATPase in the stomach through K+ competitive binding. (IC 50: 1.0 ± 0.2 μM), it has a strong inhibitory effect on acid. Linaprazan (AZD0865) mesylate can be used for research on reflux esophagitis with oral activity .
loading...
    loading...
Cat. No.: HY-19865
CAS No.: 955095-47-3
Target:  

Na+/K+ ATPase

Research Areas:  

Inflammation/Immunology

Azeloprazole sodium is an orally active proton pump inhibitor. Azeloprazole sodium irreversibly binds to and blocks the proton pump (H +/K +-ATPase) on parietal cells, thereby inhibiting gastric acid secretion. Azeloprazole sodium is primarily metabolized by the CYP3A4 enzyme, and its pharmacokinetics and acid-suppressive effects are independent of CYP2C19 activity. Azeloprazole sodium can be used for research on acid-related diseases such as reflux esophagitis and gastroesophageal reflux disease .
loading...
    loading...
Cat. No.: HY-109023
CAS No.: 955095-45-1
Target:  

Na+/K+ ATPase

Research Areas:  

Inflammation/Immunology

Azeloprazole is an orally active proton pump inhibitor. Azeloprazole irreversibly binds to and blocks the proton pump (H +/K +-ATPase) on parietal cells, thereby inhibiting gastric acid secretion. Azeloprazole is primarily metabolized by the CYP3A4 enzyme, and its pharmacokinetics and acid-suppressive effects are independent of CYP2C19 activity. Azeloprazole can be used for research on acid-related diseases such as reflux esophagitis and gastroesophageal reflux disease .
loading...
    loading...
Cat. No.: HY-100412R
CAS No.: 248919-64-4
Synonyms: AZD0865 (Standard)
Research Areas:  

Cancer

Linaprazan (Standard) is the analytical standard of Linaprazan. This product is intended for research and analytical applications. Linaprazan (AZD0865) can inhibit H+,K+ -ATPase in the stomach through K+ competitive binding, (IC50: 1.0 ± 0.2 μM), it has a strong inhibitory effect on acid. Linaprazan (AZD0865) can be used for research on reflux esophagitis with oral activity .
loading...
    loading...
Cat. No.: HY-109023A
CAS No.: 955095-50-8
Target:  

Na+/K+ ATPase

Research Areas:  

Inflammation/Immunology

Azeloprazole potassium is an orally active proton pump inhibitor. Azeloprazole potassium irreversibly binds to and blocks the proton pump (H +/K +-ATPase) on parietal cells, thereby inhibiting gastric acid secretion. Azeloprazole potassium is primarily metabolized by the CYP3A4 enzyme, and its pharmacokinetics and acid-suppressive effects are independent of CYP2C19 activity. Azeloprazole potassium can be used for research on acid-related diseases such as reflux esophagitis and gastroesophageal reflux disease .
loading...
    loading...
Cat. No.: HY-N17783A
CAS No.: 163860-24-0
Sanleng acid is an unsaturated fatty acid compound that can be isolated from the hexane extract of Magnolia sieboldii (MsHE). MsHE can inhibit the expression of inflammatory mediators (such as COX-2) and pro-inflammatory cytokines (such as TNF-α, IL-1β), and increase the expression of tight junction proteins (claudin-4, claudin-5) to protect epithelial cell barrier function, thus exerting anti-inflammatory activity. Related compounds may be used in research related to reflux esophagitis (RE).
loading...
    loading...